Categories

Genotyping Market by Technology (Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI_TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology) & by Products – Global Forecast to 2020

US$ 4650

“Genotyping is used to study genetic variation in the genotypes of living organisms, including humans, animals, plants, and microorganisms. The genotyping market is mainly driven by technological advancements, increasing incidence of genetic diseases and awareness on personalized medicine, decreasing prices of DNA sequencing, growing importance of SNP genotyping in drug development, and the growing demand for genotyping of animal and plant livestock. However, ambiguity in the reimbursement for these products and a lack of well-trained lab technicians are drivers expected to restrain the growth of this market in the forecast period.

07-26 2015   Pages: 183

Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) – Forecast to 2019

US$ 4650

“The bioburden testing market is expected to reach $565.6 million by 2019 from $354.4 million in 2014, at a CAGR of 9.8% from 2014 to 2019. This market is segmented on the basis of products, test types, applications, end users, and regions. On the basis of end users, the market is segmented into pharmaceutical and biotechnology companies, medical device manufacturers, contract manufacturing organizations (CMOs), manufacturers of food & beverage and agricultural products, and microbial testing laboratories.

07-26 2015   Pages: 146

Live Cell Imaging Market by Product (Equipment, Consumables, Software), Technology (Fluorescence Recovery after Photobleaching, High-Content Screening) & by Application (Cell Biology, Stem Cells, Drug Discovery) – Analysis & Global Forecast to 2019

US$ 4650

“Over the years, the live cell imaging market has witnessed various technological advancements in order to study the functions of live cells that meet the needs of academic and government institutes, pharmaceutical and biotechnology industries, contract research organizations, and diagnostics laboratories. These advancements have led to the development of various technologies used for live cell imaging.

07-26 2015   Pages: 193

Mycoplasma Testing Market by Products (Instruments, Kits & Reagents, Services), Application (Cell Line, Virus, End of Production Cells), Technology (PCR, ELISA, Direct Assay), End User (Cell Banks, Pharmaceutical Companies) – Global Forecast to 2019

US$ 4650

“The global mycoplasma testing market is expected to reach $613.49 million by 2019 from $340.29 million in 2014, growing at a CAGR of 12.51% between 2014 and 2019. The mycoplasma testing product segments included in this report are instruments, kits & reagents, and services. The kits & reagents segment is further divided on the basis of type into stains, elimination kits, PCR assays, nucleic acid detection kits, standards & controls and other kits & reagents. The technology segments

07-26 2015   Pages: 174

Cell Counting Market by Product [Instruments (Spectrophotometer, Cell Counter, Hemocytometer, Flow Cytometer, Hematology Analyzer) Consumables (Reagent, Assay Kits, Microplate)], End User (Pharmaceutical, Hospital, Research) – Global Forecast to 2020

US$ 4650

“Over the past five years, the cell counting market has witnessed tremendous growth primarily due to high prevalence of AIDS and cancer across the globe and increasing stem cell research expenditure.

In this report, the global cell counting market is segmented on the basis of products, end users, and by region. On the basis of products, the cell counting market is categorized into

07-26 2015   Pages: 189

Genome Editing / Genome Engineering Market by Application (Cell Line Engineering, Animal & Plant Genetic Engineering), Technology (CRISPR, Antisense, TALEN, Zinc Finger Nuclease) & End User (Biotechnology & Pharmaceutical, CRO) – Global Forecast to 2019

US$ 4650

“In this report, the genome editing market is segmented on the basis of applications, technologies, end users, and regions. The application segments included in this report are cell line engineering, animal genetic engineering, plant genetic engineering, and other applications. The genome editing market, by technology, is categorized into CRISPR, TALEN, ZNF, antisense technology, and other technologies. The end-user segment includes biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations (CROs).

07-26 2015   Pages: 155

Protein Purification & Isolation Market by Technology (Precipitation, Dialysis, Electrophoresis, Western Blotting, Ion Exchange & Affinity Chromatography) by Product (Instruments, Kits, Reagents, Resins) by Application & End User – Global Forecast to 2020

US$ 4650

“Protein purification involves the process of isolating proteins from the source, based on differences in their physical properties. The objective of a protein purification process is to isolate the largest amount of functional protein with fewest contaminants. The global protein purification and isolation market is expected to grow at a CAGR of around 5% to 6% during the forecast period.

07-26 2015   Pages: 251

Antibody Production Market by Product (Equipment, Consumables), Type (Monoclonal, Polyclonal), Technology (Hybridoma) & by End-User (Biopharmaceutical Companies, Diagnostic Labs, Research Institutes) – Analysis & Global Forecast to 2019

US$ 5650

“Over the years, the antibody production market has witnessed various technological advancements in order to produce antibodies that meet the needs of biotechnology and biopharmaceutical companies, diagnostic laboratories, and research institutes. These advancements have led to the development of hybridoma-free technologies such as recombinant technology and antibody phage-display technology. Due to the advantages of this technology, such as ease of use and versatility, the hybridoma-free technology is set to replace technologies that use hybridomas and animals in due course.

07-26 2015   Pages: 164

Biological Safety Testing Market by Application (Stem Cell, Blood, Gene Therapy), Product (Instruments, Services, Kits, Reagents), & Test (Bioburden, Endotoxin, Cell Line Authentication, Residual Contamination, Adventitious Agents) – Global Forecast to 2019

US$ 4650

“The biologics safety testing market is growing at a favorable rate. The major drivers for the market include growth of the pharmaceutical and biological industries and an increasing number of new drug launches. Over the years, the number of drug approvals in North American countries has increased. Between 2001 and 2010, the FDA approved 225 drug applications and Health Canada approved 99. In addition, according to WIPO, Europe accounted for 3,822 of the pharmaceutical and 1,998 of the biotechnology patents granted in 2012.

07-26 2015   Pages: 171

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Segment (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) – Global Forecast to 2020

US$ 4650

“Developing Asian countries such as China and India are lucrative markets for bioinformatics, owing to an increasing number of contract research organizations (CROs), rise in public and private sector investment, and growing industry -academia partnerships.

07-26 2015   Pages: 186
Contact With Us
Join templatemonster at google+
Customized Research
Request Sample